Oral care compositions comprising phosphono-phosphate and anionic group containing polymers

US11370863B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11370863-B2
Application numberUS-202017087651-A
CountryUS
Kind codeB2
Filing dateNov 3, 2020
Priority dateDec 11, 2017
Publication dateJun 28, 2022
Grant dateJun 28, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are oral care compositions of novel phosphono-phosphate and anionic group containing polymer compositions that have targeted uses with divalent cations and surfaces having divalent cations. These compounds can be used to deliver anionic character to surfaces such as calcium hydroxyapatite for use in oral care applications.

First claim

Opening claim text (preview).

What is claimed is: 1. An oral care composition comprising a polymer comprising a phosphono-phosphate group and an anionic group, wherein said polymer has the structure: wherein: R 1 is selected from the group consisting of —H, alkyl, alkanediyl-alkoxy, metal salt having Na, K, Ca, Mg, Mn, Zn, Fe, or Sn cation, amine cation salt, and a structure of Formula 2: wherein: θ is the site of attachment to Formula 23, R 4 and R 5 are independently selected from the group consisting of —H, alkyl, alkanediyl-alkoxy, metal salt having Na, K, Ca, Mg, Mn, Zn, Fe, or Sn cation, and amine cation salt; R 2 is selected from the group consisting of —H, alkyl, alkanediyl-alkoxy, metal salt having Na, K, Ca, Mg, Mn, Zn, Fe, or Sn cation, amine cation salt, and a structure of Formula 3: wherein: θ is the site of attachment to Formula 23, R 6 , and R 7 are independently selected from the group consisting of —H, alkyl, alkanediyl-alkoxy, metal salt having Na, K, Ca, Mg, Mn, Zn, Fe, or Sn cation, and amine cation salt, and n is an integer from 1 to 22; and R 3 is selected from the group consisting of —H, alkyl, alkanediyl-alkoxy, metal salt having Na, K, Ca, Mg, Mn, Zn, Fe, or Sn cation, and amine cation salt, and said anionic group is covalently bound to the polymer backbone, side group, or side chain and is selected from the chemical group consisting of phosphate, phosphonate, phosphinate, sulfate, sulfonate, sulfinate, mercapto, carboxylate, hydroxyamino, amine oxide, and hydroxamate, R 8 is selected from the group consisting of —H and —CH 3 ; L 1 is selected from the group consisting of a chemical bond, arenediyl, and a structure of Formula 5: wherein: α is the site of attachment to the polymer backbone; β is the site of attachment to the phosphono-phosphate; X is selected from the group consisting of the structures in Formulas 6-12; wherein: R 9 is selected from the group consisting of —H, alkyl (C1-8) , phosphonoalkyl, and phosphono(phosphate)alkyl; and Y is selected from the group consisting of alkanediyl, alkoxydiyl, alkylaminodiyl and alkenediyl, R 11 is selected from the group consisting of —H and —CH 3 ; δ is the site of attachment to the anionic group; L 3 is selected from a chemical bond, arenediyl, and a structure of Formula 15; wherein: γ is the site of attachment to the polymer backbone; δ is the site of attachment to the anionic group; W is selected from the structures in Formulas 16-22: wherein: R 12 is selected from the group consisting of —H and alkyl (C1-8) ; and V is selected from the group consisting of alkanediyl, alkoxydiyl, alkylaminodiyl or alkenediyl; R 13 is a chemical group resulting from polymer initiation; R 14 is a chemical group resulting chain termination; m is an integer from 2 to 450; and p is an integer from 2 to 450. 2. The oral care composition of claim 1 wherein R 2 is a group having a structure: wherein: θ is the site of attachment to Formula 23, R 6 , and R 7 are independently selected from the group consisting of —H, alkyl, alkanediyl-alkoxy, metal salt having Na, K, Ca, Mg, Mn, Zn, Fe, or Sn cation, and amine cation salt, and n is an integer from 1 to 3. 3. The oral care composition of claim 1 wherein R 8 is H. 4. The oral care composition of claim 1 wherein L 1 is a group having the structure: wherein: α is the site of attachment to the polymer backbone; β is the site of attachment to the phosphono-phosphate; X is selected from the group consisting of the structures: wherein: R 9 is selected from the group consisting of —H, alkyl (C1-8) , phosphonoalkyl, and phosphono(phosphate)alkyl; and Y is selected from the group consisting of alkanediyl, alkoxydiyl, alkylaminodiyl and alkenediyl. 5. The oral care composition of claim 1 wherein said anionic group is selected from the group consisting of phosphate, phosphonate, sulfate, sulfonate, and carboxylate. 6. The oral care composition of claim 1 wherein R 11 is H. 7. The oral care composition of claim 1 wherein L 3 is a group having the structure: wherein: W is selected from the group consisting of the structures: 8. The oral care composition of claim 1 wherein R 13 is selected from the group consisting of the structures: wherein: R 15 is selected from the group consisting of —H, Na, K and amine cation salt; τ is the site of attachment to polymer backbone; and Q is the non-olefin residue of a monomer used in polymerization. 9. The oral care composition of claim 8 wherein Q has the structure: wherein κ denotes the site of attachment to Formula 28. 10. The oral care composition of claim 8 wherein Q has the structure: wherein κ denotes the site of attachment to Formula 28. 11. The oral care composition of claim 1 wherein R 14 is —H. 12. The oral care composition of claim 1 wherein R 14 is another polymer chain with a head to head attachment. 13. The oral care composition of claim 1 wherein: R 1 , R 2 , and R 3 are independently selected from the group consisting of H, Na salt, K salt and amine cation salt; R 8 is H; L 1 is a covalent bond; L 3 is a covalent bond; the anionic group is sulfonate; R 13 has the structure: wherein τ is the site of attachment to polymer backbone; and Q has a structure selected from the group consisting of: wh

Assignees

Inventors

Classifications

  • having two phosphorus atoms as ring hetero atoms in the same ring · CPC title

  • the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative · CPC title

  • containing polyether sequences · CPC title

  • the unsaturation being in acrylic or methacrylic groups · CPC title

  • Introducing phosphorus atoms or phosphorus-containing groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11370863B2 cover?
Disclosed are oral care compositions of novel phosphono-phosphate and anionic group containing polymer compositions that have targeted uses with divalent cations and surfaces having divalent cations. These compounds can be used to deliver anionic character to surfaces such as calcium hydroxyapatite for use in oral care applications.
Who is the assignee on this patent?
Procter & Gamble
What technology area does this patent fall under?
Primary CPC classification C08F220/382. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).